Zealand Pharma A/S Net Asset Quality Index
Zealand Pharma A/S net asset quality index. Zealand Pharma A/S (ZEAL) has a Net Asset Quality Index of 90.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Dkr16.46 Billion minus total liabilities of Dkr1.63 Billion yields net assets of Dkr14.83 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how high is Zealand Pharma A/S's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zealand Pharma A/S (2007–2025)
Net asset quality index of Zealand Pharma A/S from 2007 to 2025. This chart shows how Zealand Pharma A/S's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of December 2025, the index stands at 90.1%, representing net assets of Dkr14.83 Billion against total assets of Dkr16.46 Billion DKK. See ZEAL book value for net asset value and shareholders' equity analysis.
Zealand Pharma A/S Net Asset Quality Index by Year (2007–2025)
Zealand Pharma A/S net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zealand Pharma A/S from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ZEAL market cap overview.
| Year | Quality Index | Net Assets (DKK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.1% | Dkr14.83 Billion | Dkr16.46 Billion | Dkr1.63 Billion | ▼ -0.6 pp |
| 2024 | 90.6% | Dkr8.62 Billion | Dkr9.51 Billion | Dkr888.86 Million | ▲ +10.2 pp |
| 2023 | 80.4% | Dkr1.59 Billion | Dkr1.98 Billion | Dkr387.15 Million | ▲ +27.5 pp |
| 2022 | 53.0% | Dkr815.91 Million | Dkr1.54 Billion | Dkr723.89 Million | ▲ +8.1 pp |
| 2021 | 44.9% | Dkr927.80 Million | Dkr2.07 Billion | Dkr1.14 Billion | ▼ -16.3 pp |
| 2020 | 61.2% | Dkr1.18 Billion | Dkr1.92 Billion | Dkr747.52 Million | ▼ -16.5 pp |
| 2019 | 77.7% | Dkr1.24 Billion | Dkr1.60 Billion | Dkr356.84 Million | ▼ -13.1 pp |
| 2018 | 90.8% | Dkr1.12 Billion | Dkr1.23 Billion | Dkr113.52 Million | ▲ +19.1 pp |
| 2017 | 71.7% | Dkr528.47 Million | Dkr737.24 Million | Dkr208.77 Million | ▲ +31.6 pp |
| 2016 | 40.0% | Dkr278.19 Million | Dkr694.63 Million | Dkr416.43 Million | ▲ +0.3 pp |
| 2015 | 39.7% | Dkr252.23 Million | Dkr634.69 Million | Dkr382.46 Million | ▼ -2.6 pp |
| 2014 | 42.4% | Dkr252.83 Million | Dkr596.76 Million | Dkr343.93 Million | ▼ -48.8 pp |
| 2013 | 91.1% | Dkr316.14 Million | Dkr346.91 Million | Dkr30.77 Million | ▼ -2.9 pp |
| 2012 | 94.0% | Dkr491.01 Million | Dkr522.40 Million | Dkr31.39 Million | ▼ 0.0 pp |
| 2011 | 94.0% | Dkr441.40 Million | Dkr469.48 Million | Dkr28.08 Million | ▲ +3.7 pp |
| 2010 | 90.4% | Dkr407.11 Million | Dkr450.55 Million | Dkr43.44 Million | ▲ +6.6 pp |
| 2009 | 83.8% | Dkr132.92 Million | Dkr158.68 Million | Dkr25.75 Million | ▼ -8.9 pp |
| 2008 | 92.6% | Dkr208.63 Million | Dkr225.24 Million | Dkr16.61 Million | ▲ +0.6 pp |
| 2007 | 92.0% | Dkr242.37 Million | Dkr263.37 Million | Dkr21.00 Million | — |